Desminopathies (DES; OMIM: 125660) are highly variable presenting as cardiomyopathy, myofibrillar myopathy (MFM) or a combination of both. Dominant mutations are more common while a few severe cases of recessive myofibrillar myopathy were reported with complete loss of desmin. Here, we report three unsolved Limb girdle congenital myasthenic syndrome (LG-CMS) patients with a recurrent homozygous intronic DES mutation identified by systematic reanalysis through Solve-RD project. Three unrelated patients (M:F – 2:1) aged 16, 21 and 22 years presented with history of delayed motor milestones, childhood onset of progressive muscle involvement. Fatigable ptosis and limb weakness was reported in all three patients with gradually progressive speech and swallowing difficulty. Elevated serum creatine kinase was common finding and repetitive nerve stimulation showed decrement (>10%) in two patients. Clinical improvement of 25% with pyridostigmine and salbutamol was noted in one patient. Initial exome sequencing analysis did not reveal any significant variants in known CMS genes. On re-analysis, we identified a novel intronic homozygous substitution DES(NM_001927.4):c.1023+5G>A in all three patients. In-silico analysis predicted pathogenicity due to altered donor splice site. Muscle biopsy in one of the male patients showed mixed pattern with reduced sarcoplasmic Desmin staining along with Desmin positive aggregates. Neuromuscular junction involvement has been previously reported in severe desmin-null patients. The presence of a recessive CMS-MFM phenotype of moderate severity with desmin aggregates and absence of cardiac involvement in our patients expands the known spectrum of Desminopathies and reiterates the importance of early genetic diagnosis to identify treatable CMS phenotypes. Due to the presence of identical rare homozygous variant in three unrelated south Indian patients, we suspect a possibility of founder allele.
Read full abstract